Identification of FDA-Approved Drugs That Increase Mevalonate Kinase in Hyper IgD Syndrome - Prestwick Chemical Libraries

Home
Libraries
Success stories
Resupply
Custom Synthesis
News
Contact

Identification of FDA-Approved Drugs That Increase Mevalonate Kinase in Hyper IgD Syndrome

All our screening libraries

Prestwick Chemical Library®
Prestwick Oncombo Library
Prestwick-Greenpharma Phytochemical Library
Prestwick Drug-Fragment Library
Greenpharma Ligand Library (LIGENDO)

Prestwick CNS-penetrant Drug Library
Prestwick GPCR Drug Library
Prestwick Peptidic Macrocycle Library
Prestwick Original Molecules Library
Prestwick C. elegans Library

Partners

Contact us

EUROPE & NORTH AMERICA
Samar Bou Zeid
JAPAN
Kenji Miura
SOUTH KOREA
MRTeck

Find us

Laboratoire GREENPHARMA

Supplier of molecules
active ingredients and R&D solutions
Prestwick Chemical Libraries is integrated into Laboratoire Greenpharma
AMBINTER

Global provider of advanced chemical molecules
Ambinter is integrated into Laboratoire Greenpharma

© 2026 Prestwick Chemical Libraries. Tous droits réservés.

This website uses cookies to ensure you get the best experience on our website and measure our frequentation.